These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3156994)

  • 1. Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties.
    Maeda H; Ueda M; Morinaga T; Matsumoto T
    J Med Chem; 1985 Apr; 28(4):455-61. PubMed ID: 3156994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic.
    Maeda H; Takeshita J; Kanamaru R
    Int J Pept Protein Res; 1979 Aug; 14(2):81-7. PubMed ID: 158571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer.
    Oda T; Maeda H
    Cancer Res; 1987 Jun; 47(12):3206-11. PubMed ID: 2953411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
    Kimoto A; Konno T; Kawaguchi T; Miyauchi Y; Maeda H
    Cancer Res; 1992 Feb; 52(4):1013-7. PubMed ID: 1531320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
    Suzuki F; Okuno Y; Maeda Y; Maeda H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3305-12. PubMed ID: 2961306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of macrophage by polyanions and its conjugated proteins and effect on cell membrane.
    Oda T; Morinaga T; Maeda H
    Proc Soc Exp Biol Med; 1986 Jan; 181(1):9-17. PubMed ID: 2935880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.
    Suzuki F; Pollard RB; Maeda H
    Cancer Immunol Immunother; 1989; 30(2):97-104. PubMed ID: 2480846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS.
    Takeshita J; Maeda H; Kanamaru R
    Gan; 1982 Apr; 73(2):278-84. PubMed ID: 6214446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stability of high molecular weight anticancer agent SMANCS and its transfer from oil-phase to water-phase. Comparative study with neocarzinostatin].
    Hirayama S; Sato F; Oda T; Maeda H
    Jpn J Antibiot; 1986 Mar; 39(3):815-22. PubMed ID: 3016359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
    Oda T; Sato F; Yamamoto H; Akagi M; Maeda H
    Anticancer Res; 1989; 9(2):261-5. PubMed ID: 2526613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative. I. Meth A tumor eradication and tumor-neutralizing activity in mice pretreated with ZSS or NCS.
    Masuda E; Maeda H
    Cancer Immunol Immunother; 1995 May; 40(5):329-38. PubMed ID: 7600566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
    Oda T; Sato F; Maeda H
    J Natl Cancer Inst; 1987 Dec; 79(6):1205-11. PubMed ID: 2961908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
    Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.
    Oda T; Yamamoto H; Miki T; Maeda H
    Jpn J Cancer Res; 1989 Apr; 80(4):394-9. PubMed ID: 2526108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced intestinal absorption of a hydrophobic polymer-conjugated protein drug, smancs, in an oily formulation.
    Oka K; Miyamoto Y; Matsumura Y; Tanaka S; Oda T; Suzuki F; Maeda H
    Pharm Res; 1990 Aug; 7(8):852-5. PubMed ID: 2146602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
    Schmitt DA; Kisanuki K; Kimura S; Oka K; Pollard RB; Maeda H; Suzuki F
    Anticancer Res; 1992; 12(6B):2219-24. PubMed ID: 1295469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor activities of oily suspended YM881 (SMANCS) against VX2 carcinoma].
    Kimura M; Konno T; Ohtsuka N; Mizumachi R; Oda T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2183-8. PubMed ID: 2544148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the cytotoxic effects of the high- and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro.
    Miyamoto Y; Oda T; Maeda H
    Cancer Res; 1990 Mar; 50(5):1571-5. PubMed ID: 2137371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimetastatic and antitumor activity of a derivative of neocarzinostatin: an organic solvent- and water-soluble polymer-conjugated protein.
    Maeda H; Takeshita J; Kanamaru R; Sato H; Khatoh J; Sato H
    Gan; 1979 Oct; 70(5):601-6. PubMed ID: 160353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F; Munakata T; Maeda H
    Anticancer Res; 1988; 8(1):97-103. PubMed ID: 2451896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.